April 01, 2021
CRISPR-Cas9 treatment of sickle cell disease has been approved for clinical trials by the U.S. Food and Drug Administration. Researchers will now test CRISPR-Cas9 on humans to directly correct the mutation in the beta-globin gene responsible for sickle cell disease.
February 22, 2021
In eukaryotes, gene expression was long held to be “monocistronic,” which means that a single gene makes messenger RNA that then encodes a single protein. In a new study published by the Proceedings of the National Academy of Sciences (PNAS), a team of researchers in professor Sabeeha Merchant‘s lab in the Department of Plant and Microbial Biology has… More
January 21, 2021
In a paper published in the journal Cell Systems, the UC Berkeley researchers describe a novel technique, based on a microfluidic platform, for unraveling and imaging lengthy strands of DNA.
December 23, 2020
New study decodes the molecular diversity of neurons in the zebrafish retina.
December 01, 2020
Graduate student Kaydren Orcutt describes how a new technique, PA-2DEV, was used to study the states involved with harvesting green light by green plants and algae.
August 11, 2020
A new study led by UC Berkeley researchers is the first to comprehensively assess the potential of genomic sequencing to reveal health problems in newborns.
August 04, 2020
Graduate student Diana Aguilar Gómez tells the story of Joana Rocha, a visiting scholar in the Rasmus Nielsen lab who ventured into the Sahara Desert to study the genetic adaptations that help desert foxes thrive in extreme environments.
July 30, 2020
Although Jennifer Doudna’s CRISPR-Cas9 has become the go-to genome editor for both basic research and gene therapy, it has spawned other potentially powerful DNA manipulation tools that could help fix genetic mutations.